VAXIGRIP TETRA 15MCG 0.5ML PRE-FILLED SYRINGE VACCINE

In stock

Only 1 left

SKU

10331009765

Quantity: Min:1 ~ Max:30000

Vaxigrip Tetra 15mcg 0.5ml Pre-filled Syringe Vaccine is a quadrivalent influenza vaccine by Sanofi Pasteur. It provides broad protection against four seasonal flu strains, including two influenza A and two influenza B types. Administered via intramuscular injection, it helps stimulate the immune system to prevent flu illness in individuals aged 6 months and older.

Details

Product Overview

Vaxigrip Tetra 15mcg 0.5ml Pre-filled Syringe Vaccine is a quadrivalent influenza vaccine meticulously crafted to offer comprehensive protection against seasonal flu.
Developed by Sanofi Pasteur, a globally recognized leader in vaccine innovation, this vaccine contains inactivated virus antigens from four distinct influenza virus strains, typically comprising two influenza A strains (H1N1 and H3N2) and two influenza B strains (Victoria and Yamagata lineages).
Its primary function is to stimulate the immune system, prompting it to produce antibodies that are essential for defending the body against future infections from these specific flu strains.
Vaxigrip Tetra is administered as an intramuscular injection and is suitable for individuals aged 6 months and older.
The exact strain composition and availability may vary seasonally and by geographical region.

Product Details

This vaccine offers key specifications for effective influenza prevention:

Manufacturer: Sanofi Pasteur
Form: Solution for injection in a pre-filled syringe
Strength: 15 micrograms of haemagglutinin per strain (60 mcg total HA)
Volume: 0.5 ml per pre-filled syringe
Administration Route: Intramuscular
Storage: Requires refrigeration (2°C - 8°C) and must not be frozen. Keep in outer carton away from light.
Type: Inactivated quadrivalent influenza vaccine

Benefits of Use

Embrace the protective advantages offered by Vaxigrip Tetra:

Provides broad-spectrum protection against four prevalent strains of the influenza virus, including two A strains and two B strains.
Significantly reduces the risk of developing severe flu illness, minimizing hospitalizations and fatalities linked to influenza infection.
Offers crucial protection for vulnerable populations, such as infants, young children, the elderly, and individuals with underlying chronic health conditions.
Features a convenient pre-filled syringe design, ensuring straightforward and efficient administration by a healthcare professional.
Backed by Sanofi Pasteur, a highly trusted and reputable name in the field of vaccine research and development.

How to Use

For optimal efficacy and safety, Vaxigrip Tetra must be administered as follows:
1. Vaxigrip Tetra should only be administered by a qualified healthcare professional.
2. The standard recommended dose is 0.5 ml for individuals aged 6 months and older.
3. The vaccine is given as a single intramuscular injection, typically into the deltoid muscle of the upper arm for adults and older children, or into the anterolateral thigh for infants and toddlers.
4. Children aged 6 months to less than 9 years who have not previously received an influenza vaccine may require a second dose after an interval of at least 4 weeks following the first dose.
5. Always adhere strictly to your healthcare provider's specific instructions regarding the vaccination schedule and any subsequent doses.

Caution & Warnings

Prior to administration, please be aware of the following important precautions:

This vaccine is intended for prescription use only and must be administered by a qualified healthcare professional.
Do not administer Vaxigrip Tetra if you have a known severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine, including egg proteins, neomycin, or formaldehyde.
It is imperative to inform your doctor or pharmacist if you are experiencing a fever, acute illness, or have any known bleeding disorder before receiving the vaccination.
As with all vaccines, Vaxigrip Tetra may cause side effects, although not everyone will experience them. Common side effects may include localized pain, redness, swelling, or tenderness at the injection site, headache, muscle aches, and low-grade fever.
Rarely, more severe allergic reactions can occur. Medical supervision is recommended during and immediately after administration.
Please note that the vaccine may not protect all vaccinated persons, and immunity typically begins approximately 2-3 weeks after vaccination.
Consult your doctor or pharmacist before use if you are pregnant or breastfeeding to discuss the benefits and potential risks.

Ingredients

Each 0.5 ml dose of Vaxigrip Tetra contains:

Active Ingredients: Inactivated split virions of influenza virus strains:

A/Victoria/2570/2019 (H1N1)pdm09-like virus (15 micrograms Haemagglutinin)
A/Darwin/9/2021 (H3N2)-like virus (15 micrograms Haemagglutinin)
B/Austria/1359417/2021-like virus (B/Victoria lineage) (15 micrograms Haemagglutinin)
B/Phuket/3073/2013-like virus (B/Yamagata lineage) (15 micrograms Haemagglutinin)

Excipients: These may include sodium chloride, potassium chloride, disodium phosphate dihydrate, monopotassium phosphate, and water for injections.
Traces: From the manufacturing process, traces of egg proteins (such as ovalbumin, chicken proteins), formaldehyde, and gentamicin may be present.

More Information

More Information
Gtin	101011004573000
Recommended Sale Price	54.35
Is Wasfaty Product	No
Brand	Vaxigrip
Ingredient Name	INFLUENZA A VIRUS A/INDONESIA/5/2005 H5N1 ANTIGEN UV FORMALDEHYDE INACTIVATED
SFDA Reg. No	2908234064
IBC	101011004573000
Drug Type	Vaccine
Scientific Name	Influenza vaccine (split virion, inactivated)
Strength	5
Strength Unit	mcg
Form	Solution for injection
Admin Route	Intramuscular
Size	0.5
Size Unit	ML
Package Types	Pre-filled syringe
Package Size	1 syringe
shelfLife	12 months
Storage conditions	Store in a refrigerator (2°C - 8°C). Do not freeze. Keep the syringe in the outer carton to protect from light.
Refrigerator Storage	Yes